Skip to main content
Figure 6 | Health and Quality of Life Outcomes

Figure 6

From: The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials

Figure 6

Medical Outcome Study Short Form 36 (SF-36) domain scores at end point (last observation carried forward) for pooled intent-to-treat subjects with *#8805; 50% or < 50% reductions in monthly migraine frequency. *p < 0.001; P = 0.007; p = 0.013; §p = 0.019, ||p = 0.026 versus < 50% responders. PF = physical functioning; BP = bodily pain; VT = vitality; GH = general health perceptions; RE = role-emotional; RP = role-physical; MH = mental health; SF = social functioning; PCS = physical component summary; MCS = mental component summary.

Back to article page